| Ytd | -36.41% | |
| 1y | -38.85% |
| Open | 4.29 | Prev Close | 4.27 | Low | 4.26 | High | 4.36 | Mkt Cap | 628.23M |
| Vol | 449.80K | Avg Vol | 1.40M | EPS | 0.34 | P/E | 12.68 | Forward P/E | 21.65 |
| Beta | 1.45 | Short Ratio | 11.09 | Inst. Own | 71.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 3.99 | 200-d Avg | 4.99 | 1yr Est | 12.20 |
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
U.S. stock futures rise, Meta shares drop 9.4%, Teladoc Health and Rentokil Initial fall after mixed
MiMedx Group, Inc. (MDXG) Q2 2026 Earnings Call Transcript
MiMedx Group NASDAQ: MDXG said it has agreed to acquire Sanara MedTech in a transaction valued at $3
Reports Second Quarter Net Sales of $64 Million Reiterates Full Year Financial Outlook on a Standal
Transformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgica
MARIETTA, Ga., July 20, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the
NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
MARIETTA, Ga., May 21, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of invest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc.
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of invest
Investors need to pay close attention to MDXG stock based on the movements in the options market lat
MiMedx Group faces a sharp downgrade from Buy to Hold as 2026 revenue guidance drops to $260–$290 mi
Flowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company's Portfolio G4Derm Plu
NEW YORK, May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors o
MiMedx Group, Inc. (MDXG) Q1 2026 Earnings Call Transcript
MiMedx (MDXG) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate
Reports First Quarter Net Sales of $59 Million Revises 2026 Net Sales and Adjusted EBITDA Expectati
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for it
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for it
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for i
On Friday morning, 446 companies hit new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to repo
During Thursday, 849 stocks hit new 52-week lows.
Wednesday's session saw 784 companies set new 52-week lows.
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to repo
During Friday's session, 445 companies made new 52-week lows.
Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly
Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs.
Before 10 a.m. ET on Wednesday, 124 companies hit new 52-week highs.
During Tuesday's morning session, 95 companies made new 52-week highs.
Tuesday's morning session saw 105 companies set new 52-week highs.
During Monday's morning session, 212 companies made new 52-week highs.
This morning 134 companies reached new 52-week highs.
This morning 263 companies set new 52-week highs.